Duquesne Family Office LLC / REGN
Duquesne Family Office LLC’s Regeneron Pharmaceuticals Position
Does Duquesne Family Office LLC own Regeneron Pharmaceuticals (REGN)? Not currently — the last reported position was 35.6K shares worth $20M in Q3 2020; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$20M
Q3 2020
Shares
35.6K
% of Portfolio
+0.58%
Quarters Held
2
position exited
Position History REGN
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of REGN.